Literature DB >> 11044890

Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.

M R Gerasimov1, M Franceschi, N D Volkow, O Rice, W K Schiffer, S L Dewey.   

Abstract

There is a greater prevalence of cigarette smoking among cocaine-dependent individuals and hyperactive children treated with stimulants (e.g., methylphenidate, MP). However, little is known about the neurochemical basis of the interaction between nicotine and cocaine or MP. It is thought that the reinforcing effects of cocaine and MP are due partly to increases in synaptic DA in the nucleus accumbens (NAc). These measurable increases are secondary to the blockade of the DA transporter. In contrast, nicotine stimulates acetylcholine receptors located presynaptically on dopaminergic projections from the ventral tegmental area (VTA) to the NAc and increases DA transmission. Here we investigate the effects of nicotine on NAc DA in animals simultaneously injected with cocaine or MP. Coadministration of nicotine (0.4 mg/kg s.c.) and cocaine (10 mg/kg i.p.) or MP (5 mg/kg i.p.) increased the extracellular NAc DA levels in an additive manner, while coadministration of nicotine (0. 4 mg/kg s.c.) and a higher dose of cocaine (20 mg/kg) or MP (10 mg/kg) clearly produced a synergistic elevation in NAc DA. These findings suggest that the degree of DA transporter (DAT) occupancy contributes to the synergistic interaction between nicotine and cocaine or MP. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044890     DOI: 10.1002/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  39 in total

1.  The neuropsychology of cocaine addiction: recent cocaine use masks impairment.

Authors:  Patricia A Woicik; Scott J Moeller; Nelly Alia-Klein; Thomas Maloney; Tanya M Lukasik; Olga Yeliosof; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein
Journal:  Neuropsychopharmacology       Date:  2008-05-21       Impact factor: 7.853

2.  In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats.

Authors:  Rajeev I Desai; David J Barber; Philip Terry
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

4.  Methylphenidate increases choice of cigarettes over money.

Authors:  William W Stoops; Mégan M Poole; Andrea R Vansickel; Kathryn A Hays; Paul E A Glaser; Craig R Rush
Journal:  Nicotine Tob Res       Date:  2010-11-08       Impact factor: 4.244

5.  Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys.

Authors:  Nancy K Mello; Jennifer L Newman
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

Review 6.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

7.  Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration.

Authors:  Samuel L Chong; Catherine M Claussen; Nachum Dafny
Journal:  Brain Res Bull       Date:  2012-01-13       Impact factor: 4.077

8.  Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate.

Authors:  Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

Review 9.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 10.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.